William W. Seeley MD
Associate Professor, Neurology, UCSF School of Medicine
Join to view full profile
400 Parnassus AveFl 8San Francisco, CA 94143
Phone+1 415-353-2273
Fax+1 415-476-4800
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 5 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. William Seeley, MD is a neurologist in San Francisco, California. He is currently licensed to practice medicine in California and Massachusetts. He is an Associate Professor at UCSF School of Medicine.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2000 - 2003
University of California (San Francisco)Residency, Internal Medicine, 1999 - 2002- University of California San Francisco School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2003 - 2028
MA State Medical License 2002 - 2004
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
Publications & Presentations
PubMed
- Correction to: Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab.Lawren VandeVrede, Renaud La Joie, Sheena Horiki, Nidhi S Mundada, Mary Koestler
Acta Neuropathologica. 2025-02-13 - 32 citationsDetection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers.Lawren VandeVrede, Hanna Cho, Mark Sanderson-Cimino, Fattin Wekselman, Yann Cobigo
JAMA Neurology. 2025-02-10 - 10 citationsClinical and neuropathological associations of plasma Aβ/Aβ, p-tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders.Binita Rajbanshi, Igor Prufer Q C Araujo, Lawren VandeVrede, Peter A Ljubenkov, Adam M Staffaroni
Alzheimer's & Dementia. 2025-01-29
Press Mentions
International Neurology Conference Featured UCSF ExpertsApril 22nd, 2025- What Is Frontotemporal Dementia? The Disease Afflicting Actor Bruce Willis Is IncurableFebruary 17th, 2023
- Tau Post-Translational Modifications: Dynamic Transformers of Tau Function, Degradation, and AggregationDecember 7th, 2020
Grant Support
- Upstream pathogenesis in familial and sporadic frontotemporal dementia and motor neuron diseaseUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2018–2029
- Frontotemporal Dementia: Genes, Images, and EmotionsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2002–2028
- Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targetsSTANFORD UNIVERSITY2024–2026
- Deep Pathological Phenotyping in Frontotemporal Dementia and Motor Neuron Disease.UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2018–2025
